Author pages are created from data sourced from our academic publisher partnerships and public sources.
Selection criteria for lung-cancer screening.
- M. Tammemägi, H. Katki, +8 authors C. Berg
- The New England journal of medicine
- 21 February 2013
BACKGROUND The National Lung Screening Trial (NLST) used risk factors for lung cancer (e.g., ≥30 pack-years of smoking and <15 years since quitting) as selection criteria for lung-cancer screening.… Expand
Overdiagnosis in low-dose computed tomography screening for lung cancer.
IMPORTANCE Screening for lung cancer has the potential to reduce mortality, but in addition to detecting aggressive tumors, screening will also detect indolent tumors that otherwise may not cause… Expand
Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Martin Tammemägi and colleagues evaluate which risk groups of individuals, including nonsmokers and high-risk individuals from 65 to 80 years of age, should be screened for lung cancer using computed… Expand
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
Background Selection of candidates for lung cancer screening based on individual risk has been proposed as an alternative to criteria based on age and cumulative smoking exposure (pack-years). Nine… Expand
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada
Background The National Lung Screening Trial (NLST) results indicate that computed tomography (CT) lung cancer screening for current and former smokers with three annual screens can be cost-effective… Expand
Application of Risk Prediction Models to Lung Cancer Screening: A Review
- M. Tammemägi
- Journal of thoracic imaging
- 1 March 2015
Globally, lung cancer is the leading cause of cancer death and is a major public health problem. Because lung cancer is usually diagnosed at an advanced stage, survival is generally poor. In recent… Expand
Selecting lung cancer screenees using risk prediction models-where do we go from here.
- M. Tammemägi
- Translational lung cancer research
The National Lung Screening Trial (NLST) demonstrated that low dose computed tomography (LDCT) screening could reduce lung cancer mortality by 20% in high-risk individuals. The United States… Expand
Impact of lung cancer screening results on smoking cessation.
- M. Tammemägi, C. Berg, T. Riley, Christopher Cunningham, K. Taylor
- Journal of the National Cancer Institute
- 1 June 2014
BACKGROUND Lung cancer screening programs may provide opportunities to reduce smoking rates among participants. This study evaluates the impact of lung cancer screening results on smoking cessation.… Expand
Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients.
- D. Brenner, M. Tammemägi, S. Bull, D. Pinnaduwaje, I. Andrulis
- Chronic diseases in Canada
Data from the Ontario Cancer Registry (OCR) were compared with data from a multi-centred prospective cohort of 1655 node-negative breast cancer patients with intensive clinical follow-up. Agreement… Expand
Risk Stratification for Second Primary Lung Cancer.
- S. Han, G. Rivera, +4 authors H. Wakelee
- Journal of clinical oncology : official journal…
- 23 June 2017
Purpose This study estimated the 10-year risk of developing second primary lung cancer (SPLC) among survivors of initial primary lung cancer (IPLC) and evaluated the clinical utility of the risk… Expand